Building on her experiences in her practice and through the ACR, this rheumatology leader and educator is eager to advance the work of the COT.

Carina Stanton, BSJ, MA, is a freelance science journalist based in Denver. She has been writing about science for more than 16 years, covering a range of healthcare topics, including rheumatology, surgery, nursing and executive leadership. Her work has appeared in newspapers, newsletters, trade and consumer magazines, books and peer-reviewed journals. Carina has also covered a range of other science news topics, including environmental science, marine biology and archaeology. She has conducted her own research in historical archaeology in Great Britain and Scotland and worked on dig sites in Northern Ireland and Wales. As a former mass media science and engineering fellow for the American Association for the Advancement of Science, Carina is inspired to advance the public understanding of science. When she is not working indoors, Carina is happy spending time outside with her husband and two young children to hike, mountain bike and help her children grow their passion for nature.
Building on her experiences in her practice and through the ACR, this rheumatology leader and educator is eager to advance the work of the COT.
Building on her experiences in her practice and through the ACR, this rheumatology leader and educator is eager to advance the work of the COT.
Dr. Feely discusses his previous work with the College, his current work as a practicing rheumatologist and how he will lead continued advances on the insurance front.
This spring, the ACR will be distributing a survey to collect data about academic and community practice productivity, finances, staffing, technology and more. It’s critical members report the most accurate data possible to help the ACR address members’ needs, and enable rheumatologists and practices maintain economic viability.
In sessions in the business of rheumatology track, rheumatology practice leaders will share ways to manage payer complexities head-on while also improving patient care.
Improving reimbursement for underwater biosimilars is just one example of how the ACR’s practice advocates have achieved solutions to members’ insurance challenges. Here’s a look at current ACR efforts in insurance advocacy and how to get help with your own insurance challenges.
It’s an election year, and ACR staff are excited about the possibility of moving key initiatives, such as Medicare reimbursement, across the finish line. But they need members’ help to do so.
Reimbursement has fallen below acquisition price for some biosimilar versions of infliximab, forcing practices and patients to make difficult decisions. The ACR is working to change this.
New Committee on Rheumatologic Care (CORC) Chair Chris Phillips, MD, talks about his past work with the ACR, his experience as a private practice rheumatologist and his plans to lead CORC in addressing practitioner pain points and supporting the business side of rheumatology practice.
Outgoing CORC Chair Marcus Snow, MD, FACR, and the College look back on the tremendous achievements made during the past three years, including pandemic care guidance, improved patient access to care and direction through new biosimilars choices.